Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spruce Biosciences Inc
(NQ:
SPRB
)
0.5358
-0.0120 (-2.19%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Spruce Biosciences Inc
< Previous
1
2
3
4
5
Next >
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
June 04, 2024
Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool.
Via
Benzinga
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Pfizer Q1 Earnings and Revenues Beat Estimates
May 01, 2024
PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago.
Via
Talk Markets
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
March 14, 2024
Spruce Biosciences faces setbacks as tildacerfont trials fail primary endpoints, raising concerns about drug efficacy and compliance. Analysts downgrade ratings and adjust price targets amid...
Via
Benzinga
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
March 14, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What 4 Analyst Ratings Have To Say About Spruce Biosciences
November 20, 2023
Via
Benzinga
Analyst Ratings for Spruce Biosciences
September 08, 2023
Via
Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
March 14, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.30% to 38,926.22 while the NASDAQ fell 0.44% to 16,107.04. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Expert Ratings for Spruce Biosciences
August 16, 2023
Via
Benzinga
Analyst Expectations for Spruce Biosciences's Future
May 16, 2023
Via
Benzinga
US Stocks Higher; Producer Prices Rise 0.6% In February
March 14, 2024
U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
March 14, 2024
Anheuser-Busch stock is falling on Thursday following news that 10% holder Altria is selling a portion of its stake in BUD shares.
Via
InvestorPlace
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
March 14, 2024
Spruce Biosciences' latest CAH studies: CAHmelia-203 & CAHptain-205. Discover insights on tildacerfont's efficacy, safety, and pharmacokinetics in adult & pediatric CAH patients.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
Why Is Fisker (FSR) Stock Down 41% Today?
March 14, 2024
Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy.
Via
InvestorPlace
Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
March 14, 2024
Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported.
Via
InvestorPlace
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 14, 2024
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 14, 2024
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 13, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 13, 2024
Pre-market stock movers are a hot topic on Tuesday and we're diving into all of the biggest winners and losers this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Top 4 Health Care Stocks That May Rocket Higher This Month
October 20, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 08, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via
Benzinga
Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
September 08, 2023
Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.
Via
Benzinga
Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
September 08, 2023
B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 27, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.